1. Home
  2. SEB vs KNSA Comparison

SEB vs KNSA Comparison

Compare SEB & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SEB

Seaboard Corporation

HOLD

Current Price

$4,279.48

Market Cap

4.3B

Sector

Industrials

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$74.82

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEB
KNSA
Founded
1918
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.9B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
SEB
KNSA
Price
$4,279.48
$74.82
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$60.86
AVG Volume (30 Days)
16.8K
421.3K
Earning Date
05-12-2026
04-28-2026
Dividend Yield
0.17%
N/A
EPS Growth
467.71
225.00
EPS
283.99
0.27
Revenue
$5,809,000,000.00
$677,564,000.00
Revenue This Year
N/A
$37.48
Revenue Next Year
N/A
$17.87
P/E Ratio
$15.13
$282.48
Revenue Growth
7.99
60.09
52 Week Low
$3,140.01
$35.29
52 Week High
$5,989.37
$82.94

Technical Indicators

Market Signals
Indicator
SEB
KNSA
Relative Strength Index (RSI) 48.70 49.48
Support Level $4,068.17 $44.95
Resistance Level $4,753.51 $81.97
Average True Range (ATR) 135.53 2.45
MACD 30.19 -0.82
Stochastic Oscillator 73.69 24.66

Price Performance

Historical Comparison
SEB
KNSA

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.

Share on Social Networks: